• Anne Brunet-Bernard, Sylvestre Maréchaux, Laurent Fauchier, Aurélie Guiot, Maxime Fournet, Amélie Reynaud, Frédéric Schnell, Christophe Leclercq, Philippe Mabo, and Erwan Donal.
• CIC-IT U 804, Centre Hospitalier Universitaire Rennes, Université Rennes 1, France; INSERM, U1099, Rennes, France; Université Rennes 1, LTSI, Rennes, France; Université François Rabelais, Tours, France; Service de Cardiologie, Centre Hospitalier Universitaire Tours, France.
• Am. J. Cardiol. 2014 Jun 15; 113 (12): 2045-51.

AbstractThe aim of this study was to evaluate whether a scoring system integrating clinical, electrocardiographic, and echocardiographic measurements can predict left ventricular reverse remodeling after cardiac resynchronization therapy (CRT). The derivation cohort consisted of 162 patients with heart failure implanted with a CRT device. Baseline clinical, electrocardiographic, and echocardiographic characteristics were entered into univariate and multivariate models to predict reverse remodeling as defined by a ≥15% reduction in left ventricular end-systolic volume at 6 months (60%). Combinations of predictors were then tested under different scoring systems. A new 7-point CRT response score termed L2ANDS2: Left bundle branch block (2 points), Age >70 years, Nonischemic origin, left ventricular end-diastolic Diameter <40 mm/m(2), and Septal flash (2 points) was calculated for these patients. This score was then validated against a validation cohort of 45 patients from another academic center. A highly significant incremental predictive value was noted when septal flash was added to an initial 4-factor model including left bundle branch block (difference between area under the curve C statistics = 0.125, p <0.001). The predictive accuracy using the L2ANDS2 score was then 0.79 for the C statistic. Application of the new score to the validation cohort (71% of responders) gave a similar C statistic (0.75). A score >5 had a high positive likelihood ratio (+LR = 5.64), whereas a score <2 had a high negative likelihood ratio (-LR = 0.19). In conclusion, this L2ANDS2 score provides an easy-to-use tool for the clinician to assess the pretest probability of a patient being a CRT responder.Copyright © 2014 Elsevier Inc. All rights reserved.

38 keywords...

hide…